Correlation Between Mordechai Aviv and Clal Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mordechai Aviv and Clal Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mordechai Aviv and Clal Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mordechai Aviv Taasiot and Clal Biotechnology Industries, you can compare the effects of market volatilities on Mordechai Aviv and Clal Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mordechai Aviv with a short position of Clal Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mordechai Aviv and Clal Biotechnology.

Diversification Opportunities for Mordechai Aviv and Clal Biotechnology

-0.73
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Mordechai and Clal is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Mordechai Aviv Taasiot and Clal Biotechnology Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clal Biotechnology and Mordechai Aviv is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mordechai Aviv Taasiot are associated (or correlated) with Clal Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clal Biotechnology has no effect on the direction of Mordechai Aviv i.e., Mordechai Aviv and Clal Biotechnology go up and down completely randomly.

Pair Corralation between Mordechai Aviv and Clal Biotechnology

Assuming the 90 days trading horizon Mordechai Aviv Taasiot is expected to generate 2.16 times more return on investment than Clal Biotechnology. However, Mordechai Aviv is 2.16 times more volatile than Clal Biotechnology Industries. It trades about 0.36 of its potential returns per unit of risk. Clal Biotechnology Industries is currently generating about -0.05 per unit of risk. If you would invest  151,200  in Mordechai Aviv Taasiot on September 1, 2024 and sell it today you would earn a total of  43,700  from holding Mordechai Aviv Taasiot or generate 28.9% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Mordechai Aviv Taasiot  vs.  Clal Biotechnology Industries

 Performance 
       Timeline  
Mordechai Aviv Taasiot 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Mordechai Aviv Taasiot are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Mordechai Aviv sustained solid returns over the last few months and may actually be approaching a breakup point.
Clal Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Clal Biotechnology Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Mordechai Aviv and Clal Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mordechai Aviv and Clal Biotechnology

The main advantage of trading using opposite Mordechai Aviv and Clal Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mordechai Aviv position performs unexpectedly, Clal Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clal Biotechnology will offset losses from the drop in Clal Biotechnology's long position.
The idea behind Mordechai Aviv Taasiot and Clal Biotechnology Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets